Border Collie Gut Health: The Gut-Brain Connection Behind Their Anxious, Seizure-Prone Mind

Summary

The Border Collie is the most neurologically intense breed in domestic dogs: extraordinary intelligence, a high-arousal temperament, and a documented predisposition to idiopathic epilepsy that carries a frequently severe clinical course. Research now shows that epileptic dogs exhibit gut dysbiosis characterised by reduced bacterial diversity and significant depletion of SCFA-producing and GABA-producing bacterial populations, with opportunistic pathogens including Escherichia coli and Clostridium perfringens elevated in their place.¹ These microbial changes are associated with impaired blood-brain barrier integrity and altered neuroinflammatory signalling via the gut-brain axis. Alongside the epilepsy picture, the Border Collie’s well-documented anxiety profile, compulsive behavioural tendencies, and noise sensitivity all map directly onto the same gut-brain bidirectional relationship. This article explains the gut health science behind the breed’s neurological and behavioural profile, and what daily microbiome support may offer.

---

Introduction

The Border Collie is defined by its mind. No other breed matches its combination of working intelligence, sustained focus, and neurological intensity, traits refined over centuries of herding work that demanded constant vigilance, rapid decision-making, and a profound sensitivity to handler cues and environmental signals. Those same traits, shaped deep into the breed’s genetic architecture, also load the nervous system in ways that carry real health consequences.

Idiopathic epilepsy is one of the most serious. It is well established within veterinary neurology that the Border Collie carries a high breed prevalence of idiopathic epilepsy (IE), with a clinical course that is frequently moderate or severe and a subset of affected dogs that proves drug-resistant.² The impact on quality of life for both dogs and owners is substantial: owner-reported quality-of-life scores are significantly lower for Border Collies with IE than for other epileptic breeds, and the outlook for young male Border Collies with early-onset seizure clusters is particularly poor.³

What has become increasingly clear over the past five years is that the gut microbiome is not a bystander to this neurological picture. Multiple peer-reviewed studies now document gut dysbiosis in epileptic dogs, characterised by specific microbial changes that connect, via the gut-brain axis, to neuroinflammation, blood-brain barrier function, and the inhibitory neurotransmitter environment in the brain. Alongside this, the Border Collie’s anxiety profile, compulsive behaviours, and high stress reactivity all involve the same bidirectional gut-brain communication pathways. Understanding gut health in this breed means understanding how the gut and the brain are talking to each other, and what happens when that conversation goes wrong.

---

Key Takeaways

• Idiopathic epilepsy is a documented, heritable predisposition in Border Collies with a frequently severe clinical course and significant drug resistance in a subset of cases.
• Epileptic dogs exhibit gut dysbiosis characterised by reduced bacterial diversity and depletion of SCFA-producing and GABA-producing bacterial populations.
• SCFAs produced by gut bacteria cross the blood-brain barrier, support its structural integrity, and modulate inhibitory neurotransmitter levels including GABA.
• The gut-brain axis operates bidirectionally: gut dysbiosis may influence neuroinflammation and seizure threshold, while epilepsy and chronic stress both disrupt the gut microbiome in return.
• The Border Collie’s anxiety predisposition, noise sensitivity, and compulsive behavioural tendencies are themselves gut-brain axis considerations, linked to the microbiome-mood relationship via the vagus nerve and HPA axis.
• No nutritional or microbiome intervention has been shown to prevent, treat, or reduce seizure frequency in Border Collies: gut health is a meaningful supportive consideration, not a therapeutic intervention for epilepsy.
• Daily microbiome support is a scientifically defensible priority for the breed across both the neurological and behavioural dimensions of its gut health profile.

---

In This Guide

• The Gut Health Profile of the Border Collie
• Idiopathic Epilepsy in the Border Collie: A Heritable and Clinically Serious Predisposition
• The Gut-Brain Axis: How the Microbiome Connects to Neurological Health in Dogs
• Gut Dysbiosis in Epileptic Dogs: What the Research Shows
• Anxiety, Stress, and the Gut-Brain Relationship in the Border Collie
• Border Collie Gut Dysbiosis: The Full Microbiome Picture
• How Bonza Supports Border Collie Gut Health
• How To Support Your Border Collie’s Gut Health: A Practical Guide
• Safety Considerations and When to See Your Vet
• Frequently Asked Questions
• Conclusion
• Related Articles
• References
• Editorial Information

---

The Gut Health Profile of the Border Collie

Border Collie gut health cannot be discussed in isolation from Border Collie neurology. The two are connected, not metaphorically but through the concrete, extensively studied signalling pathways of the gut-brain axis: a bidirectional communication system involving the vagus nerve, the hypothalamic-pituitary-adrenal (HPA) axis, the enteric nervous system, and the metabolites produced by the gut microbiome.

The breed’s gut health story is therefore told through two overlapping lenses. The first is idiopathic epilepsy: a heritable neurological condition with high breed prevalence, a serious clinical phenotype, and a growing body of research documenting how gut dysbiosis in epileptic dogs may relate to the neuroinflammatory and neurotransmitter disruption that underlies seizure activity. The second is the breed’s behavioural profile: the anxiety, noise sensitivity, compulsive tendencies, and stress reactivity that are characteristic of Border Collies and that load the gut-brain bidirectional relationship in ways that are relevant to microbiome health.

These two lenses converge. A nervous system running at sustained high intensity exerts chronic demand on the gut-brain axis. Gut dysbiosis may amplify the very neurological and behavioural vulnerabilities that define the breed. Understanding this relationship is the starting point for thinking clearly about Border Collie gut health.

---

Idiopathic Epilepsy in the Border Collie: A Heritable and Clinically Serious Predisposition

Idiopathic epilepsy (IE) is a common neurological diagnosis in dogs, with a general canine population prevalence estimated at 0.6 to 0.75%.⁴ In the Border Collie, the prevalence is substantially and consistently reported as higher than the population average across multiple epidemiological studies and across different geographic populations, making it one of the most affected breeds.⁴

The clinical phenotype in Border Collies is defined by severity. In the foundational study of IE in this breed, a cohort of 49 Border Collies presented with moderate clinical courses in 33% of cases and severe clinical courses in 49% of cases, characterised by a high prevalence of cluster seizures and status epilepticus.² This places the Border Collie among the breeds with the most clinically demanding IE presentations in veterinary neurology. Survival time was significantly reduced in dogs with onset before two years of age and in those with a severe clinical course.²

A later multicentre study examining 116 Border Collies with IE found that 60% of medically treated dogs required two or more antiseizure medications, a figure that reflects both the frequency of suboptimal drug response in this breed and the drug resistance that characterises a significant subset of affected individuals.⁵ Owner-reported quality-of-life scores in Border Collies with IE are significantly lower than in Golden Retrievers or Labrador Retrievers with the same diagnosis, and approximately 39% of owners in one study reported a decline in their dog’s quality of life of 50% or more.⁵

The mode of inheritance has not been precisely determined in Border Collies, but genetic studies consistently support heritable mechanisms, and a familial predisposition is recognised within the breed.² Stress has been specifically identified as a seizure-precipitating factor in Border Collies with IE, an important intersection given the breed’s documented sensitivity to environmental stressors.³

---

The Gut-Brain Axis: How the Microbiome Connects to Neurological Health in Dogs

The gut-brain axis is the bidirectional communication network linking the gastrointestinal tract and the central nervous system. In the context of neurological and behavioural health, the most clinically significant of its mechanisms involve the gut microbiome directly.

Short-chain fatty acids (SCFAs), produced by the bacterial fermentation of dietary fibre in the large intestine, are central to this relationship. SCFAs, particularly butyrate, propionate, and acetate, cross the blood-brain barrier (BBB) via monocarboxylate transporters on endothelial cells.¹⁰ Once in the central nervous system, they contribute to BBB structural integrity by supporting the expression of tight junction proteins, regulate levels of inhibitory neurotransmitters including GABA and glutamate in the hypothalamus, exert anti-inflammatory and immunomodulatory effects on microglial cells, and provide a neuroprotective energy substrate for brain metabolism.¹⁰ ¹¹

When SCFA-producing bacterial populations are depleted through gut dysbiosis, all of these functions are compromised. Reduced butyrate and propionate levels are associated with increased BBB permeability, elevated neuroinflammatory cytokine activity, and a shift in the excitatory-inhibitory neurotransmitter balance towards excess excitation, which lowers the threshold at which seizure activity can occur.¹¹

The gut also communicates directly with the brain via the vagus nerve, which transmits signals from the enteric nervous system to the brainstem, and via the HPA axis, through which psychological stress triggers hormonal cascades that reach the gut and alter microbial composition. Gut bacteria themselves synthesise or stimulate the production of neuroactive compounds: approximately 90% of the body’s serotonin is produced in the gut, and the gut microbiome modulates the availability of serotonin precursors, dopamine precursors, and GABA.¹⁰ This is the mechanism through which the gut genuinely earns its description as the body’s second brain, not as metaphor but as a functional description of its role in the neurotransmitter environment.

A 2022 systematic review of human and veterinary evidence confirmed that gut microbiota modulation of neuroinflammation, including through Th-17 cell activation, pro-inflammatory cytokine production, and SCFA reduction, represents the best characterised mechanism through which dysbiosis may contribute to epileptogenesis.¹⁰

---

Gut Dysbiosis in Epileptic Dogs: What the Research Shows

The evidence base for gut dysbiosis in canine idiopathic epilepsy has grown substantially since 2021 and now spans multiple independent study populations and methodologies.

The first direct investigation of faecal microbiota in dogs with IE compared epileptic drug-naive dogs with healthy controls and found significantly reduced abundance of GABA-producing bacteria (including Pseudomonadales, Pseudomonadaceae, and Pseudomonas graminis) and SCFA-producing bacteria (including Peptococcaceae, Ruminococcaceae, and Anaerotruncus), as well as bacteria associated with reduced risk for brain disease (Prevotellaceae) in epileptic dogs.⁶ The researchers noted that because GABA is the principal inhibitory neurotransmitter in seizure control, and because SCFAs regulate GABA and glutamate levels in the central nervous system, these microbial depletions carry mechanistic as well as associative significance.⁶

A more recent study published in 2025, comparing 19 drug-naive epileptic dogs with 17 healthy controls, corroborated these findings and added critical detail.¹ Epileptic dogs showed a marked reduction in bacterial richness and a trend towards lower microbial evenness. Specific beneficial genera including Faecalibacterium, Prevotella, and Blautia were reduced, while opportunistic pathogens including Escherichia coli, Clostridium perfringens, and Bacteroides were elevated.¹ The authors concluded that these alterations in microbiome diversity and composition may contribute to epilepsy via the gut-brain axis and identified dietary and probiotic interventions targeting gut microbiota modulation as a priority area for further research.¹

Further mechanistic evidence comes from research examining the enteric nervous system directly. A 2024 pilot study applied faecal supernatants from dogs with IE, including phenobarbital-responsive and phenobarbital-non-responsive dogs, to cultured myenteric neurons and found that supernatants from drug-non-responsive epileptic dogs induced action potential discharge in a significantly higher proportion of enteric neurons.⁸ This indicates that the altered microbial environment in non-responsive epileptic dogs actively activates the enteric nervous system in ways that healthy controls do not, adding a functional dimension to the compositional dysbiosis picture.

Work examining the effect of phenobarbital treatment on faecal microbiota found that phenobarbital increased fecal SCFA concentrations after 90 days of treatment, and that higher butyrate levels were specifically associated with phenobarbital-responsive dogs compared with non-responsive dogs.⁷ This finding suggests that SCFA levels may have relevance to therapeutic response as well as to the underlying microbiome-neurological relationship in IE.

Across this body of research, several important caveats apply. Study populations remain small, control for confounding variables including diet is inconsistent across studies, and the direction of causality, whether dysbiosis contributes to epileptogenesis or epilepsy drives dysbiosis, has not been established.¹² What can be stated is that gut dysbiosis is consistently present in epileptic dogs, that the specific microbial changes observed have mechanistic plausibility via the gut-brain axis, and that this is an active and growing area of veterinary research with meaningful implications for how we think about supporting neurological health through microbiome maintenance.

---

Anxiety, Stress, and the Gut-Brain Relationship in the Border Collie

Independent of the epilepsy picture, the Border Collie’s behavioural profile is itself a gut-brain axis consideration of direct relevance to gut health.

A large-scale behavioural survey of over 13,700 Finnish pet dogs across 264 breeds found that Border Collies displayed a very high prevalence of compulsive behaviours, specifically compulsive staring and fly snapping, both of which reflect the breed’s inherited herding instincts expressed in an environment that cannot fulfil their working purpose.¹³ Noise sensitivity, anxiety, and stress reactivity are also widely documented in the breed, with herding dogs including Border Collies consistently identified as among the most sensitive to environmental stressors.¹³

These behavioural traits are not simply temperamental inconveniences. They reflect sustained activation of the HPA axis and the sympathetic nervous system, producing chronic low-grade stress states that the gut-brain axis registers directly. Chronic stress reduces microbial diversity, selectively depletes beneficial bacterial populations, compromises gut barrier integrity, and amplifies the very anxiety and stress reactivity that triggered the dysbiosis in the first place.¹⁴ ¹⁵ This bidirectional amplification loop is particularly relevant in a breed whose baseline nervous system arousal is already high.

The gut’s role as the body’s primary serotonin production site connects the microbiome directly to mood regulation. Gut bacteria modulate the availability of tryptophan, the precursor to serotonin, and the serotonin signalling environment through which emotional states including anxiety and behavioural reactivity are regulated. Dysbiosis that disrupts this serotonin-relevant microbial activity contributes, via the gut-brain axis, to the very anxiety profile that characterises the breed.¹⁵

For Border Collie owners whose dogs show anxiety, noise sensitivity, or compulsive behaviours, the gut-brain relationship is therefore a meaningful dimension of their dog’s overall health picture, not an alternative explanation for what is happening but a contributory mechanism operating alongside the genetic, developmental, and environmental factors that shape the individual dog’s behavioural profile.

---

Border Collie Gut Dysbiosis: The Full Microbiome Picture

When the epilepsy and anxiety dimensions of the Border Collie’s gut health profile are considered together, the full microbiome picture comes into focus.

The breed faces a compound demand on the gut-brain axis. If epilepsy is present, the documented dysbiosis associated with IE depletes the bacterial populations that produce SCFAs and GABA, compromises the inhibitory neurotransmitter signalling environment, increases neuroinflammatory risk through BBB disruption, and activates the enteric nervous system in ways that amplify the neurological burden.¹ ⁶ ⁷ ⁸

Even in Border Collies without epilepsy, the breed’s high-arousal, anxiety-prone temperament creates chronic HPA axis loading that the gut microbiome registers and responds to. Chronic stress disrupts the microbial community, reduces SCFA-producing bacteria, lowers gut barrier integrity, and sets up the bidirectional amplification between dysbiosis and stress reactivity that makes a difficult behavioural profile harder to manage.¹⁴ ¹⁵

In dogs where epilepsy and anxiety coexist, which is not uncommon given the shared neurological architecture, these mechanisms interact and reinforce each other. The microbiome is positioned at the intersection of both, and microbiome support is therefore a meaningful and scientifically defensible consideration across the full spectrum of the breed’s gut-brain health demands.

The Border Collie does not have a gut condition in the conventional sense of chronic enteropathy or food sensitivity. The gut health concern in this breed is neurological and behavioural in its expression, with the microbiome as the connecting tissue.

---

How Bonza Supports Border Collie Gut Health

Biotics: The Daily Microbiome Foundation for Every Border Collie

Biotics is the essential daily recommendation for every Border Collie owner, regardless of whether epilepsy or anxiety is present. It is built on the full Biotics Triad, which addresses all three dimensions of microbiome support in a single formulation.

The prebiotics in Biotics selectively nourish SCFA-producing bacterial populations, directly supporting the microbial communities whose depletion is specifically documented in epileptic dogs and whose products are central to BBB integrity and inhibitory neurotransmitter signalling. The probiotic component is Calsporin® (Bacillus velezensis DSM 15544), the live probiotic in the Biotics formulation, a spore-forming strain with documented stability and gut colonisation capacity that supports microbial diversity and barrier function. The postbiotic component comprises TruPet™, derived from a proprietary fermentation process, alongside L. helveticus HA-122, a separate heat-inactivated postbiotic that contributes to immune modulation and gut-brain signalling without requiring live colonisation.

For a breed in which SCFA-producing and GABA-producing bacteria are specifically and consistently reduced in the context of its most serious neurological predisposition, and in which chronic neurological arousal and anxiety continuously load the gut-brain bidirectional relationship, daily microbiome support through the full Biotics Triad is a meaningful and well-grounded daily priority.

Bliss: The Primary Secondary Recommendation for Anxious Border Collies

For Border Collie owners whose dogs show anxiety, noise sensitivity, stress-related behavioural signs, or a generally reactive and high-arousal temperament, Bliss is the most clinically coherent secondary recommendation.

Bliss is formulated for dogs with stress, anxiety, or nervousness and operates directly through the gut-brain axis. Its ingredient profile targets the neuromodulatory and microbiome-related mechanisms through which the gut influences mood, stress reactivity, and behavioural regulation. Used alongside daily Biotics, Bliss provides targeted support at both the microbiome foundation level and the neuromodulatory level for the specific gut-brain profile that defines the anxious Border Collie.

Belly: The Alternative for Digestive-First Presentations

For Border Collies where the clinical presentation centres on digestive irregularity, gut sensitivity, or loose stools alongside any neurological or behavioural concerns, Belly is the appropriate secondary recommendation.

Belly supports mucosal lining integrity and gut motility, addressing the structural and functional dimensions of gut barrier health that underpin healthy microbial composition and SCFA production. It is the right secondary choice where the gut health picture is primarily digestive rather than behavioural in its expression, and it works alongside Biotics to provide both microbiome and mucosal support.

For a full explanation of the three-layer prebiotic, probiotic and postbiotic framework that underpins these recommendations, see Gut Health Supplements for Dogs: Why Probiotics Alone Are Not Enough.

---

How To Support Your Border Collie’s Gut Health: A Practical Guide

---

Safety Considerations and When to See Your Vet

The gut-brain science discussed in this article is associative and mechanistic. Gut dysbiosis is consistently documented in epileptic dogs, and the pathways through which microbial changes may influence neuroinflammation and seizure threshold are increasingly characterised. However, no dietary or supplementary intervention has been shown to prevent, treat, or reduce seizure frequency in Border Collies or in dogs with idiopathic epilepsy more broadly. If your Border Collie has seizures or you suspect epilepsy, this requires prompt veterinary assessment and, where appropriate, referral to a veterinary neurologist.

Seek veterinary advice promptly if your dog experiences a first seizure or cluster seizure, if previously controlled epilepsy changes in pattern or frequency, if anxiety behaviours escalate or change significantly in character, if digestive signs including persistent loose stools or weight loss accompany any of the above, or if you notice any sudden or unexplained change in behaviour or neurological function.

Bonza Biotics, Bliss, and Belly are all intended to complement, not replace, veterinary care. Always consult your veterinarian before making changes to the supplement or dietary regimen of a dog with a diagnosed neurological condition.

---

Frequently Asked Questions

---

Conclusion

This is where the series ends, and it is the right place to end. Ten breeds, ten distinct gut health profiles, and the gut-brain axis reserved for last, for the breed whose entire identity is its mind and whose gut health story is written entirely through the connection between that mind and its microbiome.

The Border Collie’s gut health profile asks something more demanding of owners than most breeds: it requires understanding that what is happening in the gut is not separate from what is happening in the brain. The dysbiosis documented in epileptic dogs is not coincidental. The depletion of the bacteria that produce the short-chain fatty acids that support the blood-brain barrier and modulate the inhibitory neurotransmitter environment is mechanistically connected to the neurological vulnerability that defines the breed’s most serious health concern. And the anxiety, stress reactivity, and high-arousal temperament that every Border Collie owner recognises are themselves part of the same gut-brain bidirectional system, loading it from the behavioural direction while dysbiosis loads it from the microbial one.

The science here is associative and still developing. No supplement prevents seizures. No probiotic reverses epilepsy. But the evidence base for microbiome dysbiosis in epileptic dogs is now substantive, replicated, and mechanistically coherent, and the case for daily microbiome support in a breed with this neurological and behavioural profile is not speculative. It is grounded in the same gut-brain axis research that is reshaping how veterinary medicine thinks about neurological and behavioural health.

Supporting the Border Collie’s gut is supporting the one system that links everything this breed most needs to protect. That is where the series ends, and that is precisely where the science is most alive.

---

Related Articles

• The Dog Gut Microbiome: Vital Key to Dog Health
• The Gut-Brain Axis in Dogs
• The Gut-Immune Axis in Dogs: How Gut Health Supports Immune Health
• Best Probiotics for Dogs: Canine Nutritionist’s Guide to Real Gut Impact
• Best Prebiotics for Dogs: Canine Nutritionist’s Complete Guide
• Gut Health Supplements for Dogs: Why Probiotics Alone Are Not Enough
• Gut Dysbiosis in Dogs: Causes, Symptoms & How to Restore Balance

---

References

1. Silvestrino M, Pirolo M, Bianco A, Castellana S, Del Sambro L, Tarallo VD, Guardabassi L, Zatelli A, Gernone F. Idiopathic epilepsy in dogs is associated with dysbiotic faecal microbiota. Anim Microbiome. 2025;7(1):31. doi: 10.1186/s42523-025-00397-w. PMID: 40148985. PMC: PMC11951594.
2. Hülsmeyer V, Zimmermann R, Brauer C, Sauter-Louis C, Fischer A. Epilepsy in Border Collies: clinical manifestation, outcome, and mode of inheritance. J Vet Intern Med. 2010;24(1):171–8. doi: 10.1111/j.1939-1676.2009.0438.x. PMID: 20391637.
3. Hamers MFN, Plonek M, Bhatti SFM, Bergknut N, Diaz Espineira MM, Santifort KM, Hasegawa D, Bhatti SFM, Matiasek K, Volk HA. Remarkable anecdotes illustrating the nature and effect of seizure-precipitating factors in Border Collies with idiopathic epilepsy. Front Vet Sci. 2023;10:1254279. doi: 10.3389/fvets.2023.1254279. PMID: 37781292. PMC: PMC10538117.
4. Hülsmeyer VI, Fischer A, Mandigers PJ, DeRisio L, Berendt M, Rusbridge C, Bhatti SFM, Pakozdy A, Patterson EE, Platt S, et al. International Veterinary Epilepsy Task Force’s current understanding of idiopathic epilepsy of genetic or suspected genetic origin in purebred dogs. BMC Vet Res. 2015;11:175. doi: 10.1186/s12917-015-0463-0. PMC: PMC4545870.
5. Hamers MFN, Bhatti SFM, van Ham LML, Bergknut N, Volk HA, Janssen WJ, De Risio L, Bhatti SFM. Phenotypic characterization of idiopathic epilepsy in Border Collies. Front Vet Sci. 2022;9:880318. doi: 10.3389/fvets.2022.880318. PMID: 35647099. PMC: PMC9133619.
6. García-Belenguer S, Grasa L, Valero O, Palacio J, Luño I, Rosado B. Gut microbiota in canine idiopathic epilepsy: effects of disease and treatment. Animals. 2021;11(11):3121. doi: 10.3390/ani11113121. PMID: 34827852. PMC: PMC8614570.
7. Watanangura A, Meller S, Suchodolski JS, Pilla R, Khattab MR, Loderstedt S, Becker LF, Bathen-Nöthen A, Mazzuoli-Weber G, Volk HA. The effect of phenobarbital treatment on behavioral comorbidities and on the composition and function of the fecal microbiome in dogs with idiopathic epilepsy. Front Vet Sci. 2022;9:933905. doi: 10.3389/fvets.2022.933905. PMID: 35990279. PMC: PMC9393180.
8. Elfers K, Watanangura A, Hoffmann P, Suchodolski JS, Khattab MR, Pilla R, Meller S, Volk HA, Mazzuoli-Weber G. Fecal supernatants from dogs with idiopathic epilepsy activate enteric neurons. Front Neurosci. 2024;18:1281840. doi: 10.3389/fnins.2024.1281840. PMID: 38356649. PMC: PMC10864448.
9. Watanangura A, Meller S, Farhat N, Suchodolski JS, Pilla R, Khattab MR, Lopes BC, Bathen-Nöthen A, Fischer A, Busch-Hahn K, Flieshardt C, Gramer M, Richter F, Zamansky A, Volk HA. Behavioral comorbidities treatment by fecal microbiota transplantation in canine epilepsy: a pilot study of a novel therapeutic approach. Front Vet Sci. 2024;11:1385469. doi: 10.3389/fvets.2024.1385469. PMID: 38978633. PMC: PMC11229054.
10. Gernone F, Uva A, Silvestrino M, Cavalera MA, Zatelli A. Role of gut microbiota through gut-brain axis in epileptogenesis: a systematic review of human and veterinary medicine. Biology. 2022;11(9):1290. doi: 10.3390/biology11091290. PMC: PMC9495720.
11. Ding M, Lang Y, Shu H, Shao J, Cui L. Microbiota-gut-brain axis and epilepsy: a review on mechanisms and potential therapeutics. Front Immunol. 2021;12:742449. doi: 10.3389/fimmu.2021.742449. PMC: PMC8480052.
12. Blanquet L, Serra D, Marrinhas C, Almeida A. Exploring gut microbiota-targeted therapies for canine idiopathic epilepsy. Int J Mol Sci. 2025;26(4):1742. doi: 10.3390/ijms26041742. PMID: 40004205. PMC: PMC11855791.
13. Salonen M, Sulkama S, Mikkola S, Puurunen J, Hakanen E, Tiira K, Araujo C, Lohi H. Prevalence, comorbidity, and breed differences in canine anxiety in 13,700 Finnish pet dogs. Sci Rep. 2020;10:2962. doi: 10.1038/s41598-020-59837-z. PMID: 32139728.
14. Patel KV, Hunt ABG, Castillo-Fernandez J, Abrams C, King T, Watson P, Amos GCA. Impact of acute stress on the canine gut microbiota. Sci Rep. 2024;14(1):18897. doi: 10.1038/s41598-024-66652-3. PMID: 39143116. PMC: PMC11324789.
15. Sacoor C, Marugg JD, Lima NR, Empadinhas N, Montezinho L. Gut-brain axis impact on canine anxiety disorders: new challenges for behavioral veterinary medicine. Vet Med Int. 2024;2024:2856759. doi: 10.1155/2024/2856759. PMC: PMC10827376.

---

Editorial Information

Field	Detail
Published	25 March 2026
Last Updated	25 march 2026 — Content and references reviewed March 2026
Reviewed by	Veterinary Advisory Board
Next Review	March 2027
Author	Glendon Lloyd, Dip. Canine Nutrition (Dist.), Dip. Dog Nutrigenomics (Dist.), Founder, Bonza
Disclaimer	This article is for informational purposes only and does not constitute veterinary advice. Always consult a qualified veterinarian before making changes to your dog’s diet or supplement regimen.